Serotonin-Plus Weight Loss

Serotonin-Plus Weight Loss operates a medical weight loss practice in Mobile, Alabama, focusing on pharmacological interventions for obesity and metabolic dysfunction. The clinic structures treatment around GLP-1 receptor agonist medications, specifically semaglutide and tirzepatide, which work by mimicking incretin hormones to regulate appetite, slow gastric emptying, and improve insulin sensitivity. Patients undergo metabolic testing before initiating therapy to establish baseline glucose metabolism, resting energy expenditure, and hormonal markers that influence weight regulation. This data informs individualized dosing protocols that adjust medication strength based on tolerance, side effect profile, and weight loss velocity rather than following standardized escalation schedules.

The Mobile clinic incorporates lipotropic injections containing methionine, inositol, choline, and B vitamins as adjunctive therapy to support hepatic fat metabolism and energy production during caloric restriction. Body composition monitoring through bioelectrical impedance analysis tracks changes in lean muscle mass versus adipose tissue throughout treatment, allowing providers to distinguish between fat loss and muscle catabolism. Patients receiving tirzepatide typically follow a different monitoring schedule than those on semaglutide due to the dual GIP/GLP-1 mechanism requiring assessment of both incretin pathways. The clinic addresses weight regain patterns by analyzing medication response curves and adjusting formulations when plateau effects occur after initial treatment phases.

Serotonin-Plus Weight Loss in Mobile provides weekly or biweekly check-ins during the initial three months of GLP-1 therapy to manage gastrointestinal side effects, which occur in approximately 40-50% of patients starting these medications. Providers adjust dosing intervals, recommend dietary modifications to minimize nausea, and monitor for rare but serious complications including pancreatitis symptoms or gallbladder dysfunction. The clinic does not prescribe GLP-1 agonists to patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 due to contraindications identified in clinical trials. Patients with type 2 diabetes receive coordinated care with their endocrinologists since these medications affect blood glucose levels and may require adjustment of other diabetic medications.

The Alabama clinic structures programs in phases: an initial assessment period including metabolic panel, thyroid function tests, and hemoglobin A1c; a titration phase lasting 8-16 weeks where medication doses increase according to tolerance; and a maintenance phase where patients continue therapy at effective doses while monitoring for weight stability. Lipotropic injections are administered weekly during active weight loss phases and may decrease to biweekly during maintenance. Body composition assessments occur monthly to ensure weight loss derives primarily from fat stores rather than muscle tissue, with protein intake recommendations adjusted if lean mass decreases beyond expected ranges during caloric deficit.

Serotonin-Plus Weight Loss serves patients throughout Mobile and surrounding Baldwin County communities, with the clinic located to provide access for residents across the Mobile Bay area. The practice requires in-person visits for initial consultations and medication initiation, with subsequent appointments available for established patients who demonstrate stable response to therapy. Patients must commit to regular monitoring since GLP-1 medications require ongoing medical supervision and are not appropriate for short-term cosmetic weight loss. The clinic provides education on post-medication weight management strategies since discontinuation of these therapies often results in weight regain without sustained lifestyle modifications and metabolic support.